Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review

---

Review Article

Author Details : Danielle Aparecida de Oliveira Marrafon, Alessandra Oliveira Silva*, Ana Flávia Amorim, Carlos Marcelo de Barros, Ricardo Radighieri Rascado, Carla Speroni Ceron, Tiago Marques dos Reis, Márcia Helena MIranda Cardoso Podestá, Daniel Augusto de Faria Almeida, Larissa Helena Torres, Marília Gabriella Alves Goulart Pereira

Volume : 11, Issue : 1, Year : 2023

Article Page : 18-25

https://doi.org/10.18231/j.jpbs.2023.004

Suggest article by email

Get Permission

---

Abstract

Chronic pain affects approximately 30 % of the world population. Tapentadol can be an analgesic option for patients who do not respond adequately to commonly used opioids. This study reviewed the general aspects of Tapentadol pain treatment and its possible association with increased oxidative stress, as well as the benefits of its association with antioxidant substances. The search was carried out in the Medline (Pubmed), Scopus, Web of Science, and Google academic databases, including studies since the registration of the drug in 2008. The selected articles were those related to the use of Tapentadol for chronic moderate to severe pain, but not cancer-related pain, in adults and the elderly. Tapentadol is a µ opioid receptors agonist and inhibits noradrenaline reuptake. Although Tapentadol causes fewer adverse effects than other conventional opioids, studies have shown the induction of oxidative stress by this drug, but without having elucidated the mechanisms.

Keywords: Adverse effects, Chronic pain, Oxidative stress, Pharmacology, Tapentadol, Analgesics, Antioxidants, Opioid

How to cite : Marrafon D A D O, Silva A O, Amorim A F, Barros C M D, Rascado R R, Ceron C S, Reis T M D, Podestá M H M C, Almeida D A D F, Torres L H, Pereira M G A G, Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review. J Pharm Biol Sci 2023;11(1):18-25

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.